Skip to main content
LabcorpInvestment

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Source: Autobound Signal API · 76 signals tracked for Labcorp · updated

Get Labcorp's live signals in Claude or ChatGPT, or by API

AskWhat changed at Labcorp this week? Use Autobound signals for labcorp.com.

What happened

Labcorp agreed to acquire select assets of BioReference Health from OPKO Health for $722 million in cash plus up to $150 million in earnouts.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide BURLINGTON, N.C. and MIAMI, Fla., Oct. 15, 2026 /PRNewswire/ -- Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK ), a multinational biopharmaceutical company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, LLC, a wholly owned subsidiary of OPKO Health. Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on clinical and women's health testing services, urology, corrections and certain operational assets, including over 80 additional patient service centers. As part of the agreement, Labcorp will also acquire BioReference Health's proprietary 4Kscore ® Test, an FDA-approved blood test that helps predict the likelihood of finding aggressive prostate cancer before a biopsy decision, making this important test more broadly available to patients across the country. When complete, the transaction is expected to provide patients, physicians and customers with greater access to Labcorp's comprehensive, high-quality laboratory services, including a broad specialty testing menu, convenient patient service center network and robust data analytics...

Keep reading with a free account

The rest of this article, and every signal for Labcorp, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Investment

What this signalsA large capital project often starts a round of vendor buying.

Amount named
$722M
Location
Burlington, North Carolina, United States

Companies

  • BioReference HealthRelated companybioreference.com

More investment signals at other companies

The full record

From the Signal API record

Numbers

Amount named in the story
$722M

Details

Assets
select assets of BioReference Health, including clinical laboratory testing businesses and over 80 patient service centers
Ticker
NYSE:LH

Topics and mentions

Asset tags

  • services

Extraction

Confidence
95%
Detected
Oct 15, 2026
signal_type
news
signal_subtype
invests_into_assets

Use this data

Get every investment signal for Labcorp and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Labcorp this week?”

  2. Send it to your own tools

    The Signal API returns investment signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/82d40e53-ebca-1810-8525-8f62c7c2dfe7 returns this record as JSON. POST /v1/companies/enrich returns every signal for labcorp.com.

{
  "signal_id": "82d40e53-ebca-1810-8525-8f62c7c2dfe7",
  "signal_type": "news",
  "signal_subtype": "invests_into_assets",
  "detected_at": "2026-10-15T11:30:00+00:00",
  "company": {
    "name": "Labcorp",
    "domain": "labcorp.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/labcorp-enters-into-agreement-with-opko-health-to-acquire-select-assets-of-bioreference-health-302909289.html",
    "title": "Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health",
    "assets": "select assets of BioReference Health, including clinical laboratory testing businesses and over 80 patient service centers",
    "ticker": "NYSE:LH",
    "excerpt": "Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide BURLINGTON, N.C. and MIAMI, Fla. , Oct. 15, 2026 /PRNewswire/ -- Labcorp (NYSE: LH ), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK ), a multinational biopharmaceutical company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health , LLC, a wholly owned subsidiary of OPKO Health. Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on clinical and women's health testing services, urology, corrections and certain operational assets, including over 80 additional patient service centers. As part of the agreement, Labcorp will also acquire BioReference Health's proprietary 4Kscore ® Test, an FDA-approved blood test that helps predict the likelihood of finding aggressive prostate cancer before a biopsy decision, making this important test more broadly available to patients across the country. When complete, the transaction is expected to provide patients, physicians and customers with greater access to Labcorp's comprehensive, high-quality laboratory services, including a broad specialty testing menu, convenient patient service center network and robust data analytics...",
    "summary": "Labcorp agreed to acquire select assets of BioReference Health from OPKO Health for $722 million in cash plus up to $150 million in earnouts.",
    "location": "Burlington, North Carolina, United States",
    "planning": true,
    "image_url": "https://mmx.prnewswire.com/media/MS1034544/Labcorp-Logo.jpg?id=OA3020441&p=facebook",
    "confidence": 0.95,
    "assets_tags": [
      "services"
    ],
    "published_at": "2026-10-15T11:30:00Z",
    "location_data": [
      {
        "city": "Burlington",
        "state": "North Carolina",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Through this transaction, Labcorp will acquire BioReference Health's laboratory testing businesses focused on clinical and women's health testing services, urology, corrections and certain operational assets, including over 80 additional patient service centers.",
    "amount_normalized": 722000000,
    "related_company_name": "BioReference Health",
    "related_company_domain": "bioreference.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.